Certificate number:RU.77.99.88.003.E.000707.02.17
Date of registration and renewal:13.02.2017
Dosage form: & nbspTablets weighing 900 mg.
Classification "Composition" & nbsp BAD - vitamin and mineral complexes
Classification "Clinical" & nbsp BAD-sources of vitamin-mineral complexes Supplements containing iron Supplements containing iodine Supplements containing zinc, copper, manganese BAA containing fluorine Supplements containing chromium Supplements containing selenium Supplements containing calcium and phosphorus
Composition: & nbspA premix of vitamins and minerals (MCC, calcium carbonate, ascorbic acid, niacinamide, ferrous sulfate, calcium pantothenate, zinc sulfate, biotin, sodium selenate, retinol acetate, pyridoxine hydrochloride, thiamine mononitrate, manganese sulfate, vitamin D3, riboflavin, folic acid, copper sulfate, potassium iodide, sodium fluoride, cyanocobalamin, chromium picolinate, sodium molybdate), calcium carbonate, Fibrulin Instant (inulin from chicory), lactulose dry "Lactusan", lactose, zinc citrate, alimentary gelatin, calcium stearate, ascorbic acid, vitamin E 50%, pineapple extract, artichoke extract, acerola extract, pomegranate extract, viburnum, watercress extract, lemon extract, sea buckthorn extract, blackcurrant extract, apple extract.
Scope: & nbspTo implement the public as a biologically active food additive - additional source of vitamins A, B1, B2, B6, B12, C, D3, E, PP, biotin, pantothenic acid, folic acid and trace elements (iodine, iron, copper, zinc, manganese, chromium, molybdenum, selenium, fluorine) containing calcium.
Suggested Usage: & nbspAdults take 1 tablet daily with meals or after meals. Duration of admission - 1 month, if necessary, reception can be repeated.
Contraindications:individual intolerance of dietary supplements, pregnancy, breast-feeding; Conditions in which iodine preparations are contraindicated.
Special instructions:Before use, it is recommended to consult with an endocrinologist.
Shelf life:3 years.
Storage conditions:Store in a dry place inaccessible to children at a temperature not exceeding 25 ° C.
Research protocols:ATreplacing the certificate of state registration No. RU.77.99.88.003.Е.011093.12.15 of 28.12.2015; expert opinions of the Federal Agency for Financial Monitoring and Certification of the Federal Service for Supervision of Consumer Rights Protection of the Russian Federation No. 10-2FTS / 4405 of 06.11.2015, No. 10-2FTS / 5231 of December 23, 2015.
Recipient:Farmatera, Open CompanyFarmatera, Open Company Russian Federation
Information update date: & nbsp02.03.2017
Instructions
Up